In this video, Michael Chiorean, MD, reviews how JAK inhibitors, IL-12/23 inhibitors, and other, newer therapies are expanding the tools for management of ulcerative colitis.
Dr Chiorean, from Virginia Mason Medical Center in Seattle, continues his discussion on available therapies for ulcerative colitis and Crohn disease, and how to stage them for the optimum patient outcomes.
In this video, Marla Dubinsky, MD, codirector of the Susan and Leonard Feinstein IBD Center at the Icahn School of Medicine at Mount Sinai in New York, discusses how to use the professional society guidelines as a framework for choosing therapeutics for patients with ulcerative colitis.
Dr Barnes discusses the factors to consider when determining when and how to position therapeutic options, including surgery, for patients with ulcerative colitis.
In this 4-minute video, Raymond Cross, MD, from the University of Maryland, reviews his discussion of managing patients with mild to moderate ulcerative colitis, which he presented at the virtual Advances in Inflammatory Bowel Disease regional meeting on September 12.
He recaps his presentation at the August 22 AIBD regional meeting on treating patients with ulcerative colitis with new and emerging therapeutic agents.
He gives us a preview of his presentation on what's new in treatment of ulcerative colitis, including JAK and IL-12/23 inhibitors, which he will give at the virtual AIBD 2020 regional meeting on August 22.
In this video, Dr Rubin, from the University of Chicago, discusses the challenges in the management of dysplasia and preventing cancer in patients with ulcerative colitis.
Edward L. Barnes, MD, MPH, from the University of North Carolina at Chapel Hill, answers our questions about the management of pouchitis in ulcerative colitis, a topic he will highlight during his session at the Advances in Inflammatory Bowel Diseases (AIBD) Regional Meeting in Baltimore.
Dr Sunanda Kane, president of the American College of Gastroenterology, discusses current guidelines for managing severe ulcerative colitis, controversies surrounding rescue treatment, and more.